HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Bonnans, C. Articles by Vachier, I. Search for Related Content PubMed PubMed Citation Articles by Bonnans, C. Articles by Vachier, I.

Glucocorticoid receptor-binding characteristics in severe asthma

Clinic of Respiratory Illness, INSERM U454-IFR 3, Arnaud de Villeneuve Hospital, CHU-Montpellier, France

CORRESPONDENCE: I. Vachier, INSERM U454, Hôpital Arnaud de Villeneuve, 371 Av du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France. Fax: 33 467521848. E-mail: vachier@montp.inserm.fr

Keywords: binding-assay technique, glucocorticoid receptor, monocytes, severe asthma

Received: July 8, 2002
Accepted February 6, 2003

This study was supported by the Direction de la Recherche Clinique, CHU Montpellier, France.

The cellular mechanisms associated with severe asthma are still poorly understood. This study investigated the association between glucocorticoid-receptor (GR) alterations and continuous oral glucocorticoid therapy requirement in severe asthma.

GR-binding affinity (K_d) and receptor number (n) in peripheral blood monocytes (PBM) obtained from 10 normal subjects, 10 untreated, intermittent asthmatics and 10severe asthmatics were assessed. Moreover, one ability of dexamethasone to inhibit regulated on activation, T-cells expressed and secreted (RANTES) release by these cells in vitro was investigated. GR-binding characteristics were studied in PBM using a ³H dexamethasone ligand-binding assay and Scatchard analysis. RANTES release was measured in the supernatant of PBM at 24 h using an enzyme-linked immunosorbent assay.

No significant differences in K_d and n were found between the three groups of patients. Dexamethasone in vitro was able to inhibit RANTES release (mean±sem), with the same concentration/response curve in intermittent, untreated asthmatics (0.47±0.22 versus 1.64±0.31 ng·mL^–1) and severe asthmatics (1.49±0.64 versus 2.59±0.77 ng·mL^–1).

This study showed that, despite long-term treatment with oral glucocorticoids, there was no evidence of abnormalities in glucocorticoid receptor-binding characteristics in severe asthma, and moreover, it was demonstrated that glucocorticoid receptors were functional in vitro.